Fig. 4.
Protective efficacies of HSV-2 gB and gD antigens in a guinea pig HSV-2 model. Female Hartley guinea pigs were immunized by intramuscular injection on days 0, 30, 51, and 79 with 20 μg gB or 20 μg HSV gD in combination with CPG/alum or DPBS (Naive). PI, postinfection. The error bars indicate standard deviations.